Vetanco S.A., through its subsidiary Bioinnovo developed and registered in Argentina the first recombinant vaccine for the control of bovine viral diarrhea virus. Vedevax, a subunit vaccine produced on a baculovirus line, and potentiated by a routing protein, produces highly protective titles in animals under control of a veterinary professional. Vedevax is another development of Bioinnovo for the world.
